One of the more challenging areas of pulmonary medicine remains elucidating the
pathogenesis of idiopathic pulmonary fibrosis (IPF). IPF is a devastating disease process …

The contribution of the immune system to idiopathic pulmonary fibrosis (IPF) remains poorly
understood. While most sources agree that IPF does not result from a primary …

Idiopathic pulmonary fibrosis (IPF) is a progressive and often fatal lung disease for which
there is no known treatment. Although the traditional paradigm of IPF pathogenesis …

Idiopathic pulmonary fibrosis (IPF) is defined as a specific form of chronic, progressive
fibrosing interstitial pneumonia of unknown cause, occurring primarily in older adults, and …

Pulmonary fibrosis is a pathologic process associated with scarring of the lung interstitium.
Interstitial lung diseases (ILDs) encompass a large and heterogenous group of disorders, a …

Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with an appalling
prognosis. The failure of anti-inflammatory therapies coupled with the observation that …

It is over 25 years since Scadding first defined the term fibrosing alveolitis. It has since been
established that complex mechanisms underlie its pathogenesis, including epithelial and …

The practise of modern medicine is unthinkable without biological markers, and their
adoption is now established in various clinical settings. Pulmonary fibrosis occurs in a …

Lung research supported by the National Heart, Lung, and Blood Institute (NHLBI) has had
important outcomes that have resulted in an infinitely better understanding of how …

Idiopathic pulmonary fibrosis (IPF) is a progressive, and invariably fatal, condition that is
believed to arise in genetically susceptible individuals as a consequence of an aberrant …